智通财经APP讯，赛生药业(06600)发布公告，于2023年1月13日，公司因集团员工按行使价2.0462港元行使根据购股权激励计划授出的1.9万份购股权而配发及发行1.9万股新股份;及于2023年1月16日，公司因集团员工按行使价2.0462港元行使根据购股权激励计划授出的1.2万份购股权而配发及发行1.2万股新股份。
于本公告日期该等已发行证券的数目如下：合共6.95亿股股份;购股权激励计划项下合共3203.34万份购股权(全部已归属)附带权利认购合共3203.34万股股份;及首次公开发售后购股权计划项下合共2151万份购股权(其中1467820份已归属)附带权利认购合共2151万股股份。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.